Search Within

Steven M Horwitz

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (45)
  2. Journal Article (39)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (85)
  2. Department of Medicine (85)
  3. Epidemiology and Biostatistics (85)
  4. Hematologic Malignancies, Division of (85)
  5. Lymphoma (85)
  6. Population Sciences Research Program (85)

More Groups

People
  1. Alison Moskowitz (65)
  2. Andrew Zelenetz (58)
  3. Ariela Noy (56)
  4. Matthew Matasar (54)
  5. Paul Hamlin (54)
  6. David Straus (53)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (12)
  6. 2020 (12)

More Years

Publications
  1. Blood (31)
  2. Hematological Oncology (11)
  3. Journal of Clinical Oncology (9)
  4. Blood Advances (8)
  5. Blood Cancer Journal (5)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Wiley Blackwell (12)
  3. American Society of Clinical Oncology (9)
  4. Nature Publishing Group (7)
  5. American Association for Cancer Research (4)
  6. John Wiley & Sons (3)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience
    Journal Article

    Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Global response score correlates with quality of life in cutaneous T-cell lymphoma
    Meeting Abstract

    Khan, N.; Drill, E.; Moskowitz, A.; Shinohara, M.; Larocca, C.; Querfeld, C.; Zain, J.; Horwitz, S.
    Quality of Life Research (2024)

    Fulltext@MSK | Save
  • Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: A phase 1b/2a trial
    Journal Article

    Horwitz, S. M.; Nirmal, A. J.; Rahman, J.; Xu, R.; Drill, E.; Galasso, N.; Ganesan, N.; Davey, T.; Hancock, H.; Perez, L.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma
    Journal Article

    Liu, Y.; Sardana, R.; Nemirovsky, D.; Frosina, D.; Jungbluth, A.; Johnson, W. T.; Vardhana, S.; Arcila, M.; Horwitz, S. M.; Derkach, A.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
    Research Letter

    Stuver, R.; Mian, A.; Brown, S.; Devlin, S.; Caimi, P. F.; Chinapen, S.; Dahi, P.; Dean, R.; Epstein-Peterson, Z. D.; Hill, B.; more...
    American Journal of Hematology (2024)

    Fulltext@MSK | Save
  • Quality of life and global response score in cutaneous T-cell lymphoma
    Meeting Abstract

    Khan, N.; Drill, E.; Moskowitz, A.; Shinohara, M. M.; Larocca, C.; Querfeld, C.; Zain, J. M.; Horwitz, S. M.
    Blood (2023)

    Fulltext@MSK | Save
  • Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save